Insights into monocyte-driven osteoclastogenesis and its link with hematopoiesis: Regulatory roles of PECAM-1 (CD31) and SHP-1

Critical Reviews in Immunology

Volumn 30, Issue 5, 2010, Pages 423-433

  Wu, Yue ^a   Madri, Joseph ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Hematopoiesis; Megakaryocyte; Monocyte; Osteoclast; PECAM 1; SHP 1

Indexed keywords

CD31 ANTIGEN; PROTEIN KINASE SYK; PROTEIN TYROSINE PHOSPHATASE SHP 1;

CELL INTERACTION; ENZYME REGULATION; HEMATOPOIESIS; HEMATOPOIETIC CELL; HUMAN; IN VIVO STUDY; INTRACELLULAR SIGNALING; LEUKOCYTE MIGRATION; MEGAKARYOCYTE; MEGAKARYOPOIESIS; MOLECULAR INTERACTION; MONOCYTE; NONHUMAN; OSTEOCLAST; OSTEOCLASTOGENESIS; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW;

EID: 78650061539     PISSN: 10408401     EISSN: None     Source Type: Journal    
DOI: 10.1615/critrevimmunol.v30.i5.20     Document Type: Review

References (61)

1. Ishii M, Saeki Y. Osteoclast cell fusion: mechanisms and molecules. Mod Rheumatol. 2008;18(3):220-7.
2. Schett G, Teitelbaum SL. Osteoclasts and arthritis. J Bone Miner Res. 2009 Jul;24(7):1142-6.
3. Boyle WJ, Simonet WS, Lacey DL. Osteoclast differentiation and activation. Nature. 2003 May 15;423(6937):337-42.
4. Asagiri M, Takayanagi H. The molecular understanding of osteoclast differentiation. Bone. 2007 Feb;40(2):251-64.
5. Teitelbaum SL. Bone resorption by osteoclasts. Science. 2000 Sep 1;289(5484):1504-8.
6. Nakashima T, Takayanagi H. Osteoimmunology: crosstalk between the immune and bone systems. J Clin Immunol. 2009 Sep;29(5):555-67.
7. Wu Y, Tworkoski K, Michaud M, Madri JA. Bone marrow monocyte PECAM-1 deficiency elicits increased osteoclastogenesis resulting in trabecular bone loss. J Immunol. 2009 Mar 1;182(5):2672-9.
8. Walker DG. Spleen cells transmit osteopetrosis in mice. Science. 1975 Nov 21;190(4216):785-7.
9. Udagawa N, Takahashi N, Akatsu T, Tanaka H, Sasaki T, Nishihara T, Koga T, Martin TJ, Suda T. Origin of osteoclasts: mature monocytes and macrophages are capable of differentiating into osteoclasts under a suitable microenvironment prepared by bone marrow-derived stromal cells. Proc Natl Acad Sci U S A. 1990 Sep;87(18):7260-4.
10. Ishii M, Egen JG, Klauschen F, Meier-Schellersheim M, Saeki Y, Vacher J, Proia RL, Germain RN. Sphingosine-1-phosphate mobilizes osteoclast precursors and regulates bone homeostasis. Nature. 2009 Mar 26;458(7237):524-8.
11. Mensah KA, Ritchlin CT, Schwarz EM. RANKL induces heterogeneous DC-STAMP(lo) and DC-STAMP(hi) osteoclast precursors of which the DC-STAMP(lo) precursors are the master fusogens. J Cell Physiol. Apr;223(1):76-83.
12. Jacquin C, Gran DE, Lee SK, Lorenzo JA, Aguila HL. Identification of multiple osteoclast precursor populations in murine bone marrow. J Bone Miner Res. 2006 Jan;21(1):67-77.
13. Leung R, Wang Y, Cuddy K, Sun C, Magalhaes J, Grynpas M, Glogauer M. Filamin A regulates monocyte migration through Rho small GTPases during osteoclastogenesis. J Bone Miner Res. 2010 May;25(5):1077-91.
14. Wang Y, Lebowitz D, Sun C, Thang H, Grynpas MD, Glogauer M. Identifying the relative contributions of Rac1 and Rac2 to osteoclastogenesis. J Bone Miner Res. 2008 Feb;23(2):260-70.
15. Koga T, Inui M, Inoue K, Kim S, Suematsu A, Kobayashi E, Iwata T, Ohnishi H, Matozaki T, Kodama T, Taniguchi T, Takayanagi H, Takai T. Costimulatory signals mediated by the ITAM motif cooperate with RANKL for bone homeostasis. Nature. 2004 Apr 15;428(6984):758-63.
16. Mocsai A, Humphrey MB, Van Ziffle JA, Hu Y, Burghardt A, Spusta SC, Majumdar S, Lanier LL, Lowell CA, Nakamura MC. The immunomodulatory adapter proteins DAP12 and Fc receptor gamma-chain (FcRgamma) regulate development of functional osteoclasts through the Syk tyrosine kinase. Proc Natl Acad Sci U S A. 2004 Apr 20;101(16):6158-63.
17. Mocsai A, Zhou M, Meng F, Tybulewicz VL, Lowell CA. Syk is required for integrin signaling in neutrophils. Immunity. 2002 Apr;16(4):547-58.
18. Indik ZK, Park JG, Pan XQ, Schreiber AD. Induction of phagocytosis by a protein tyrosine kinase. Blood. 1995 Mar 1;85(5):1175-80.
19. Zou W, Kitaura H, Reeve J, Long F, Tybulewicz VL, Shattil SJ, Ginsberg MH, Ross FP, Teitelbaum SL. Syk, c-Src, the alphavbeta3 integrin, and ITAM immunoreceptors, in concert, regulate osteoclastic bone resorption. J Cell Biol. 2007 Mar 12;176(6):877-88.
20. Granot-Attas S, Elson A. Protein tyrosine phosphatases in osteoclast differentiation, adhesion, and bone resorption. Eur J Cell Biol. 2008 Sep;87(8-9):479-90.
21. Dustin LB, Plas DR, Wong J, Hu YT, Soto C, Chan AC, Thomas ML. Expression of dominant-negative src-homology domain 2-containing protein tyrosine phosphatase-1 results in increased Syk tyrosine kinase activity and B cell activation. J Immunol. 1999 Mar 1;162(5):2717-24.
22. Ganesan LP, Fang H, Marsh CB, Tridandapani S. The protein-tyrosine phosphatase SHP-1 associates with the phosphorylated immunoreceptor tyrosine-based activation motif of Fc gamma RIIa to modulate signaling events in myeloid cells. J Biol Chem. 2003 Sep 12;278(37):35710-7.
23. Huang ZY, Hunter S, Kim MK, Indik ZK, Schreiber AD. The effect of phosphatases SHP-1 and SHIP-1 on signaling by the ITIM- and ITAM-containing Fcgamma receptors FcgammaRIIB and FcgammaRIIA. J Leukoc Biol. 2003 Jun;73(6):823-9.
24. Umeda S, Beamer WG, Takagi K, Naito M, Hayashi S, Yonemitsu H, Shultz LD. Deficiency of SHP-1 protein-tyrosine phosphatase activity results in heightened osteoclast function and decreased bone density. Am J Pathol. 1999 Jul;155(1):223-33.
25. Newman PJ. The biology of PECAM-1. J Clin Invest. 1997 Dec 1;100(11 Suppl):S25-9.
26. Wu Y, Welte T, Michaud M, Madri JA. PECAM-1: a multifaceted regulator of megakaryocytopoiesis. Blood. 2007 Aug 1;110(3):851-9.
27. Biswas P, Canosa S, Schoenfeld D, Schoenfeld J, Li P, Cheas LC, Zhang J, Cordova A, Sumpio B, Madri JA. PECAM-1 affects GSK-3beta-mediated beta-catenin phosphorylation and degradation. Am J Pathol. 2006 Jul;169(1):314-24.
28. Wu Y, Stabach P, Michaud M, Madri JA. Neutrophils lacking platelet-endothelial cell adhesion molecule-1 exhibit loss of directionality and motility in CXCR2-mediated chemotaxis. J Immunol. 2005 Sep 15;175(6):3484-91.
29. Payne GW, Madri JA, Sessa WC, Segal SS. Histamine inhibits conducted vasodilation through endothelium-derived NO production in arterioles of mouse skeletal muscle. FASEB J. 2004 Feb;18(2):280-6.
30. Ilan N, Madri JA. PECAM-1: old friend, new partners. Curr Opin Cell Biol. 2003 Oct;15(5):515-24.
31. Ilan N, Cheung L, Miller S, Mohsenin A, Tucker A, Madri JA. Pecam-1 is a modulator of stat family member phosphorylation and localization: lessons from a transgenic mouse. Dev Biol. 2001 Apr 1;232(1):219-32.
32. Ilan N, Cheung L, Pinter E, Madri JA. Platelet-endothelial cell adhesion molecule-1 (CD31), a scaffolding molecule for selected catenin family members whose binding is mediated by different tyrosine and serine/threonine phosphorylation. J Biol Chem. 2000 Jul 14;275(28):21435-43.
33. Ilan N, Mahooti S, Rimm DL, Madri JA. PECAM-1 (CD31) functions as a reservoir for and a modulator of tyrosine-phosphorylated beta-catenin. J Cell Sci. 1999 Sep;112 Pt 18:3005-14.
34. Gratzinger D, Barreuther M, Madri JA. Platelet-endothelial cell adhesion molecule-1 modulates endothelial migration through its immunoreceptor tyrosine-based inhibitory motif. Biochem Biophys Res Commun. 2003 Jan 31;301(1):243-9.
35. Solowiej A, Biswas P, Graesser D, Madri JA. Lack of platelet endothelial cell adhesion molecule-1 attenuates foreign body inflammation because of decreased angiogenesis. Am J Pathol. 2003 Mar;162(3):953-62.
36. Cao MY, Huber M, Beauchemin N, Famiglietti J, Albelda SM, Veillette A. Regulation of mouse PECAM-1 tyrosine phosphorylation by the Src and Csk families of protein-tyrosine kinases. J Biol Chem. 1998 Jun 19;273(25):15765-72.
37. Kalu DN, Salerno E, Liu CC, Ferarro F, Arjmandi BN, Salih MA. Ovariectomy-induced bone loss and the hematopoietic system. Bone Miner. 1993 Nov;23(2):145-61.
38. Rothe L, Collin-Osdoby P, Chen Y, Sunyer T, Chaudhary L, Tsay A, Goldring S, Avioli L, Osdoby P. Human osteoclasts and osteoclast-like cells synthesize and release high basal and inflammatory stimulated levels of the potent chemokine interleukin-8. Endocrinology. 1998 Oct;139(10):4353-63.
39. Kollet O, Dar A, Shivtiel S, Kalinkovich A, Lapid K, Sztainberg Y, Tesio M, Samstein RM, Goichberg P, Spiegel A, Elson A, Lapidot T. Osteoclasts degrade endosteal components and promote mobilization of hematopoietic progenitor cells. Nat Med. 2006 Jun;12(6):657-64.
40. Wei S, Siegal GP. Mechanisms modulating inflammatory osteolysis: A review with insights into therapeutic targets. Pathol Res Pract. 2008;204(10):695-706.
41. Kim K, Kim JH, Lee J, Jin HM, Lee SH, Fisher DE, Kook H, Kim KK, Choi Y, Kim N. Nuclear factor of activated T cells c1 induces osteoclast-associated receptor gene expression during tumor necrosis factor-related activation-induced cytokine-mediated osteoclastogenesis. J Biol Chem. 2005 Oct 21;280(42):35209-16.
42. Kacena MA, Ciovacco WA. Megakaryocyte-bone cell interactions. Adv Exp Med Biol.658:31-41.
43. Bord S, Frith E, Ireland DC, Scott MA, Craig JI, Compston JE. Megakaryocytes modulate osteoblast synthesis of type-l collagen, osteoprotegerin, and RANKL. Bone. 2005 May;36(5):812-9.
44. Chagraoui H, Tulliez M, Smayra T, Komura E, Giraudier S, Yun T, Lassau N, Vainchenker W, Wendling F. Stimulation of osteoprotegerin production is responsible for osteosclerosis in mice overexpressing TPO. Blood. 2003 Apr 15;101(8):2983-9.
45. Kacena MA, Horowitz MC. The role of megakaryocytes in skeletal homeostasis and rheumatoid arthritis. Curr Opin Rheumatol. 2006 Jul;18(4):405-10.
46. Paling NR, Welham MJ. Tyrosine phosphatase SHP-1 acts at different stages of development to regulate hematopoiesis. Blood. 2005 Jun 1;105(11):4290-7.
47. Wickrema A, Chen F, Namin F, Yi T, Ahmad S, Uddin S, Chen YH, Feldman L, Stock W, Hoffman R, Platanias LC. Defective expression of the SHP-1 phosphatase in polycythemia vera. Exp Hematol. 1999 Jul;27(7):1124-32.
48. Ravid K, Lu J, Zimmet JM, Jones MR. Roads to polyploidy: The megakaryocyte example. J Cell Physiol. 2002 Jan;190(1):7-20.
49. Muntean AG, Pang L, Poncz M, Dowdy SF, Blobel GA, Crispino JD. Cyclin D-Cdk4 is regulated by GATA-1 and required for megakaryocyte growth and polyploidization. Blood. 2007 Jun 15;109(12):5199-207.
50. Listi F, Caruso C, Balistreri CR, Grimaldi MP, Caruso M, Caimi G, Hoffmann E, Lio D, Candore G. PECAM-1/CD31 in infarction and longevity. Ann N Y Acad Sci. 2007 Apr;1100:132-9.
51. Dore AI, Santana-Lemos BA, Coser VM, Santos FL, Dalmazzo LF, Lima AS, Jacomo RH, Elias J Jr, Falcão RP, Pereira WV, Rego EM. The association of ICAM-1 Exon 6 (E469K) but not of ICAM-1 Exon 4 (G241R) and PECAM-1 Exon 3 (L125V) polymorphisms with the development of differentiation syndrome in acute promyelocytic leukemia. J Leukoc Biol. 2007 Nov;82(5):1340-3.
52. Khazen D, Jendoubi-Ayed S, Aleya WB, Sfar I, Mouelhi L, Matri S, Najjar T, Filali A, Gorgi Y, Abdallah TB, Ayed K. Polymorphism in ICAM-1, PECAM-1, E-selectin, and L-selectin genes in Tunisian patients with inflammatory bowel disease. Eur J Gastroenterol Hepatol. 2009 Feb;21(2):167-75.
53. Burim RV, Teixeira SA, Colli BO, Peria FM, Tirapelli LF, Marie SK, Malheiros SM, Oba-Shinjo SM, Gabbai AA, Lotufo PA, Carlotti-Júnior CG. ICAM-1 (Lys469Glu) and PECAM-1 (Leu125Val) polymorphisms in diffuse astrocytomas. Clin Exp Med. 2009 Jun;9(2):157-63.
54. Chung SA, Criswell LA. PTPN22: its role in SLE and autoimmunity. Autoimmunity. 2007 Dec;40(8):582-90.
55. Humphrey MB, Lanier LL, Nakamura, MC. Role of ITAM-containing adapter proteins and their receptors in the immune system and bone. Immunol Rev. 2005;208:50-65.
56. Zhu J, Emerson SG. Hematopoietic cytokines, transcription factors and lineage commitment. Oncogene. 2002;21(21):3295-313.
57. Kacena MA, Nelson T, Clough ME, Lee SK, Lorenzo JA, Gundberg CM, Horowitz MC. Megakaryocyte-mediated inhibition of osteoclast development. Bone. 2006 Nov;39(5):991-9.
58. Humphrey MB, Lanier LL, Nakamura MC. Role of ITAM-containing adapter proteins and their receptors in the immune system and bone. Immunol Rev. 2005;208:50-65.
59. Zhu J, Emerson SG. Hematopoietic cytokines, transcription factors and lineage commitment. Oncogene. 2002;21(21):3295-313.
60. Kacena MA, Horowitz MC. The role of megakaryocytes in skeletal homeostasis and rheumatoid arthritis. Curr Opin Rheumatol. 2006 Jul;18(4):405-10.
61. Kacena MA, Nelson T, Clough ME, Lee SK, Lorenzo JA, Gundberg CM, Horowitz MC. Megakaryocyte-mediated inhibition of osteoclast development. Bone. 2006 Nov;39(5):991-9.